April 29, 2026 ยท WDAY ยท Gojo

Workday Q1 FY2026 โ€” 30% Non-GAAP Margins, AI Doubles, But Macro Delays Cloud the Setup

Non-GAAP margin expansion to 30% and AI contract value doubling YoY are real. Deal delays and slowing FY27 guidance are also real. Here's how to think about it.

The Numbers (Q1 FY2026)

  • Total Revenue: $2.240B โ€” +12.6% YoY
  • Subscription Revenue: $2.059B โ€” +13.4% YoY
  • GAAP Operating Income: $39M (1.8% margin) โ€” hit by $166M restructuring charges
  • Non-GAAP Operating Income: $677M โ€” 30.2% margin (vs 25.9% prior year; +430 bps)
  • New AI Contract Value: More than doubled YoY
  • AI Product Attach Rate: ~25% of Q1 customer expansions included at least one AI product
  • ARR Milestones: Technology/media and manufacturing verticals each crossed $1B ARR
  • Buyback: New $1B Class A share repurchase authorized

What's Working

The margin story is the headline. Non-GAAP operating margin at 30.2% โ€” up from 25.9% a year ago โ€” is evidence that Workday's restructuring is delivering. They cut costs, kept revenue growing at 12.6%, and expanded margins by 430 basis points. That's the right direction on a per-dollar-of-revenue basis.

The AI attach rate of 25% on customer expansions is early but meaningful. Workday's HCM (Human Capital Management) and financial management suites have 18-month switching costs baked in โ€” once AI modules are embedded, churn risk compresses even further. AI contract value doubling YoY suggests the land-and-expand motion is working.

Two verticals crossing $1B ARR (tech/media and manufacturing) signals diversification away from pure tech-sector concentration. Manufacturing is a durability signal โ€” it's a sticky, non-cyclical buyer.

What's Clouding the Picture

Q2 subscription revenue guidance of $2.355B is a QoQ decline from Q1's $2.059B run-rate annualized trajectory. Management cited delayed deals โ€” procurement cycles are stretching as enterprise buyers tighten capital budgets in the current macro environment.

FY27 subscription revenue growth guidance was revised to 12โ€“13%, down from earlier expectations closer to 15%. That's the number the market is punishing. When enterprise SaaS decelerates, analysts reprice multiples aggressively โ€” even when the underlying FCF and margin story is improving.

The $166M restructuring charge in Q1 is a one-time item but signals the company is still in cost optimization mode, not expansion mode. That limits top-line acceleration in the near term.

LEAP Setup

  • Watch Zone: $116โ€“$120 โ€” approach signals growing setup quality
  • Entry Zone: $110โ€“$115 โ€” 52-week low flush, full LEAP sizing
  • Analyst Consensus: Buy; avg PT ~$208 (69% upside from the $123 area)
  • Thesis: Enterprise HCM leader, 18-month switching cost moat, 30%+ non-GAAP margins, AI attach doubling
  • Thesis Invalidation: Subscription revenue growth falls below 10%, AI attach rate stalls below 20%, or a major customer churns publicly

Trade Evaluation

Setup: Enterprise software with 30% non-GAAP margins, doubling AI revenue attach, and a $1B buyback trading near 52-week lows on deal timing concerns.

Risk: Delayed deals don't close โ€” they cancel. FY27 guidance misses again. Macro slowdown in IT spend extends through 2026. AI disruption to the HCM layer accelerates (low probability near-term, but real long-term).

Size: At watch zone ($116โ€“120), start building with 30โ€“40% of intended position. Full size at $110โ€“115 flush. The deal delay narrative is a timing issue, not a thesis break โ€” unless it repeats next quarter.

Invalidation: Close below $100 with worsening subscription revenue guidance or customer churn. Exit if FY27 growth falls below 10%.

Target: $175โ€“$200 over 12โ€“18 months. At $115 entry, that's 52โ€“74% on the underlying. LEAP on $140 strike provides asymmetric leverage on thesis confirmation.

The One Thing to Watch Next Quarter

Whether those delayed deals closed. Management was explicit that Q1 deals slipped โ€” not canceled. If Q2 shows subscription revenue reacceleration back above $2.1B+ annualized growth pace, the thesis is intact and the stock likely reprices toward $150+. If deals slip again, the thesis needs revisiting.

Bottom Line

Workday is a fundamentally sound enterprise platform that's being priced for disruption it hasn't experienced. 30% non-GAAP margins, AI contracts doubling, and a $1B buyback are not the metrics of a company losing its footing. The near-term pain is real โ€” deal delays and guidance cuts compress multiples. But at $110โ€“115, you're buying enterprise HCM infrastructure at a fraction of analyst fair value, with a catalyst (deal close confirmation) that's one quarter away.